Skip to content
Ontario Rheumatology Association
  • Login
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory

Government Affairs

Jane Purvis • Edition: Fall 2020

The Government Affairs committee remains active on several fronts.

Because of our widening mandate, we changed our name from “Exceptional Access Program” committee to “Government Affairs.”

We continue to meet with the MoH EAP every 3-4 months and maintain close communications with them around issues related to biologics, biosimilars and new limited use products.

We have created a new biosimilars form, which includes the name, LU code and indications for all the biosimilars we have available and this document will be kept up to date on the ORA website. We have also met with the three Rituximab biosimilar providers, to outline the rheumatology community’s needs and expectations around these new products and their availability to our patients.

The Ministry of Health’s electronic EAP portal, SADIE, has moved to a new phase where you can now create delegates who can fill in the electronic forms for you, thought he prescriber still needs to sign off on the final form prior to e-submission. The various patient support programs are training on this new platform at this time.

Finally, the Government Affairs Committee remains engaged with the Ministry of Health in regards to their biosimilar transition planning and any further details on this will be relayed to ORA members as they become available.

Other Articles in the Fall 2020 Newsletter

  • President's Message
  • OMA Section on Rheumatology Report
  • Announcing the Retirement of Denis Morrice, ORA Executive Director
  • News From Ottawa: Recent Practice Announcements
  • 2021 Membership Renewals Now Open!
  • Northern Ontario Committee
  • Communications Update
  • MoH Announcement:Transition to Publicly Funded Shingrix® Vaccine for Ontario’s Shingles Immunization Program (For Patients 65-70 Years of Age)
Editions
  • Winter 2021
  • Fall 2020
  • Summer 2020
  • Winter 2020
  • Winter 2019
  • Fall 2019
  • Spring 2019
  • Winter 2018
  • Fall 2018
  • Summer 2018
  • Summer 2017
  • Spring 2017
  • Fall 2017
  • Archive
  • Meet the Speakers: ORA 20th Annual Scientific Meeting
Committees
Communications Informatics Models of Care OMA
Tags
Biosimilar CSDTH Models of Care OBRI OMA pCPA SADIE

Contributors

The ORA’s executive members are the core contributors to the newsletter. The ORA welcomes guest contributions to the newsletter from members-at-large and others in the rheumatology community.

Contributors
Ontario Rheumatology Association

© 2020 Ontario Rheumatology Association. All Rights Reserved. Website by Digital Chaos Inc.

  • About
  • Annual Awards
  • Events
  • EAP & Limited Use Codes
  • Exceptional Access Program
  • EAP Forms and Downloads
  • Limited Use Codes
  • NIHB Drug List
  • MOHLTC IVIG Request Form
  • Informatics
  • Members
  • Member Directory
  • Past Meeting Resources
  • Peer Mentor Forum
  • BecomeA Member
  • Renew Membership
  • News
  • Newsletters
  • Drug Shortages Info
  • Other Publications
  • Info Hub
  • Contact
  • Privacy